Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Zhongguo Shi Yan Xue Ye Xue Za Zhi|July 4, 2007
[Preparation of placenta factor and its immunoregulatory effects on lymphocytes in vitro]Chen-Hua Yan, Dao-Pei LuBeijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 22, 2005
[Relation between the expression of sIL-2R and the relapse in patients with acute lymphoblastic leukemia]Jin Liu, Deng-shu Wu, Shen Zhang, et al.European Journal of Haematology|July 11, 2013
Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factorsChen-Hua Yan, Jing-Zhi Wang, Dai-Hong Liu, et al.Cancer Communications (London, England)|February 10, 2021
Pre-transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donorsYu-Qian Sun, Lan-Ping Xu, Kai-Yan Liu, et al.Clinical Transplantation|June 17, 2014
The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantationXiao-Su Zhao, Yu Wang, Chen-Hua Yan, et al.The Journal of Infection|June 18, 2016
Poor CMV-specific CD8+ T central memory subset recovery at early stage post-HSCT associates with refractory and recurrent CMV reactivationJing Liu, Ying-Jun Chang, Chen-Hua Yan, et al.Annals of Hematology|May 31, 2019
Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantationYu-Qian Sun, Yu Wang, Xiao-Hui Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2017
A Retrospective Study of Central Nervous System Invasive Fungal Disease after Allogeneic Stem Cell Transplantation: Risk Factors, Clinical Characteristics, and OutcomesYu-Qian Sun, Zhao-Yu Liu, Xiao-Jun Huang, et al.Clinical Lymphoma, Myeloma & Leukemia|October 16, 2020
Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation Compared With Chemotherapy as Postremission Treatment of Children With Intermediate-risk Acute Myeloid Leukemia in First Complete RemissionYu-Juan Xue, Yi-Fei Cheng, Ai-Dong Lu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2020
Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating FactorFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.Pageof 16